[go: up one dir, main page]

WO2007065359A1 - A material with blood compatibility and preparation method thereof - Google Patents

A material with blood compatibility and preparation method thereof Download PDF

Info

Publication number
WO2007065359A1
WO2007065359A1 PCT/CN2006/003304 CN2006003304W WO2007065359A1 WO 2007065359 A1 WO2007065359 A1 WO 2007065359A1 CN 2006003304 W CN2006003304 W CN 2006003304W WO 2007065359 A1 WO2007065359 A1 WO 2007065359A1
Authority
WO
WIPO (PCT)
Prior art keywords
materials
blood
anticoagulant
cells
compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2006/003304
Other languages
French (fr)
Chinese (zh)
Inventor
Yongnian Yan
Xiaohong Wang
Feng Lin
Zhuo Xiong
Rendong Wu
Renji Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsinghua University
Original Assignee
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsinghua University filed Critical Tsinghua University
Publication of WO2007065359A1 publication Critical patent/WO2007065359A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42Anti-thrombotic agents, anticoagulants, anti-platelet agents

Definitions

  • the general solution is to use the surface to enhance its anticoagulant performance. Once the surface of the material is divided into and etc., its anticoagulant properties will drop or disappear. The material is in contact with the blood and maintains the anticoagulant performance of the phase. The use is generally only small to
  • an endothelial cell He assumes that the same phenomenon as nickel implanted in the body can avoid the direct connection of blood and implants to prevent coagulation.
  • the most used raw material for artificial blood vessels is ethylene vinyl.
  • Artificial blood vessels with an inward greater than or equal to are generally. Maintain the tightness and make the surroundings attached to the outside of the blood vessel and inwardly covered the endothelial cells.
  • the 6-meter-long straight straight artificial blood vessel is generally made of ethylene, which is a biologically inert material that does not need to cover endothelial cells to prevent blood clotting. Artificial blood vessels with diameters under 6 m are not available on the bed.
  • Po y hyd oxya ka oa e PH is a poly scaffold material of 0 octanoic acid.
  • the inner has a porous P scaffold. It works on the PH of the outer pore of the cell.
  • the thickness of the sheep is 1.5. k ason et al. N k aso LE aoJ bo ea. Fu coaae es gon V o. ce ce
  • Po y e hane or U is a poly-material containing amino groups, each with good stitchability, and good molding processing has been
  • Butyric acid and 3 copolymerized Po (3 hyd oxybu yae co 3 hyd oxyhexa oa e), or PHBHHx, is an internal bacterium 5 synthesized by bacteria in the form of granular inclusions.
  • PHBHHx is a promising new type of bio-composite material, which has similar plasticity performance and biodegradability of plastics obtained from petrochemical raw materials.
  • PHBHHx has been used as a scaffold material for cells, cells, chondrocytes, etc. ang hao K hen.
  • B o a e a s 200 4 04 045 its mechanical strength and biocompatibility are better than other PLL PL, PHB, etc. but the rate is very high.
  • Group rate matches the multi-faceted performance material.
  • each blood-compatible material provided in this book is to convert the polymer material with a force of 00 force to a percentage of the force of 0%. A high score of 20 is in the solution. Dissolve the anticoagulant material to form a milky, slurry, or still. Follow the method described below or 2 or 3 to obtain a blood compatible material
  • Civil polymer material strength, all copolymerization, inner copolymerization also polymer, ethylene carbonic acid, carbonic acid, propylene, aromatic, 3 butyric acid and 3 copolymerization, Lactic acid, internal lactic acid copolymer, butyric acid, ethoxyl, ethylene oxide, ethylene vinyl acetate copolymer, ethene, polyvinyl chloride, polypropylene, propylene, carbonic acid, ethene, ethene acetate, ethene acetate, ethene, polyvinyl chloride, Dimethicone copolymerization, copolymerization of living and polymerization, ethylene, one or a mixture of ethylene, anticoagulant biomaterials, anticoagulant, epinephrine, thiophene, anti-inflammatory, anti-inflammatory, it, basified sulfate, Water, inhibitory or oxygen-inhibiting sucrose, d-rotation, Na NHH
  • the mixture is made of thin films,,,,,, or blood-soluble extracorporeal materials or organ materials implanted within the rest of the time by the rapid prototyping or method of making the material uniform or.
  • Anticoagulant material Dissolve the anticoagulant material with the following method, add the anti-coagulant material to the dissolved anticoagulant material solution by the amount of 0.0.
  • the inner or outer surface of the shape-like or arhat-like blood-compatible material is composed of cells, thousands of cells, cells, cells, islet cells or cardiomyocytes, or cells and self-coagulated blood are mixed, and the syringe is injected into the organ materials formed by the pipeline system . Inject or inject the cells on the surface or inside of the material, cytophobia factor or serum.
  • the blood-compatible biomaterials prepared by the above methods are also covered by this book.
  • the percentage content in the following is as the percentage of the special uniform force.
  • the method in the following is a special uniform force method.
  • the material is composed of materials and anticoagulant biomaterials that are dissolved and mixed into or filled with,,,, rapid prototyping or Zhufa made of thin films, hollow hollow,, shape or Axius for external use of blood-compatible biomaterials or implantation
  • PHB polyvinyl chloride
  • the P LPE with an average molecular weight of 0 is U
  • the method of P LPE PU material research in 2003 is to prepare 0 L of 4 dioxins to form 9 P LPE solutions. 0 in the beaker. Add nL to dissolve the solution in water. The upper P LPE solution was mixed according to the ratio of Huby 000, fully and evenly divided into the mixture.
  • Each step can be used as a biological material for dialysis, plasma and bio-intracellular support. It can also be used as an endothelial cell, cell or cell on the upper and lower surfaces of the organ, which can be used as a blood vessel, etc. Below is the effect of blood vessels
  • Step 1 The compatibility of each can be used for each of them. It can also be combined with endothelial cells, cells and functions on its upper and lower surfaces.
  • the gap material is gradually completed in half a year.
  • the method in 2004 4 255 26 was prepared by refluxing in 00 mL at 6 C. Then, the PHBHHx solution with an average molecular weight of 0 was 500 g 2 n to remove insoluble particles. Add PHBHHx of 93 to it. The PHBHHx is evenly divided into a poly- 9 of 0 to a force of 8 in a polymer solution of 9 m in chloroform. Then, 0 L of polymer solution, 5 L of 9 aqueous solution of blood compatible polymers are mixed. Pour the solution onto the plate 3 of material.
  • the various materials can be used in the cardiovascular system.
  • P LPE PU materials are based on the copolymerization (P LPE) with an average molecular weight of 20 and 29 forces.
  • the method described in 2003 prepared 0.29 lactic acid copolymer (PL Biotechnology Co., Ltd.), which was evenly divided into 0.
  • the weight of Na and the weight of 20 are the high scores used in the materials P LPE and PL.
  • the weight is 0.5 L.
  • the solution is added to the weight of P LPE PL 0.
  • the aqueous solution of Yi 3 was poured on the upper film of ethylene.
  • Step A nickel thin film material is used for atrium.
  • New Zealand white rabbits were Barbie anesthetized and her skin was removed. Or, the bone marrow cells in the bone marrow are divided into a large number of the above-mentioned blood-compatible materials.
  • the rabbits were anesthetized with a barium anesthesia with a diameter of one atrium, and the material with a diameter of 4 that was combined with the self-resting bone marrow cells was sutured with 80 ° to the rabbit at the atrial gap so as not to suture the outer skin.
  • Mu injected the powder of 40 into the abdomen during L chloride injection. 12 10 rabbits on the complete material. 2 step
  • Polylactic acid (PLL Biotechnology Co., Ltd.) with an average molecular weight of 20 force and polylactic acid (PLL Biotechnology Co., Ltd.) with an average molecular weight of 30 force and a force of 30 force is added to the material and
  • the PLL weight is 0 in L.
  • the neutralization in water is the polymer material used and the PLL weight 0 in Na is fully stirred to remove the high score in the material mixing. Mix high scores with materials and rest on ethylene. Hemocompatibility is high on films. Ten thousand principles through rapid prototyping on the high scores on the film. Each high score for the stent material.
  • the rabbit cardiomyocytes were combined with 0 neo-Xinda rabbits from the skin, and the outer skin of each rabbit was anesthetized to remove the fat and suture. A large amount of nickel fat cells in the fat group will convert cardiomyocytes. 0. L-digested cardiomyocytes are dissolved in L PB solution and then on the blood-compatible polymer film. The above 0 rabbits were anesthetized under Barbie anesthesia, respectively, and the one with myocardial cells was inserted in the atrium opening. Mu injected 20 powder into the abdomen in L sodium chloride injection. Wood 2 0 rabbits in the atrium good material 2 0 rabbits were anesthetized in New Zealand University Place the atrium all the way to the notch. The above method straight to 4 m is combined with the high score of cardiomyocytes in the membrane 80.
  • Polyethylene carbonate which is evenly divided into the quantity 0, and Sanan Chemical Co., Ltd. is equally divided into the quantity 10, the strength of the polyethylene PET Chemical Co., Ltd., the ratio of ethylene carbonate to ethylene, and the ratio of 2 to 4 dioxins.
  • Ethylene carbonate and ethene weight adrenaline phosphate dissolve and the high molecular weight ethene carbonate and ethene weight 0 NHH in the mixed solution.
  • the rapid prototyping principle is based on the principle of 10,000, and it will be highly divided into the multi-branch piping and support system inside the mixed solution at low temperature. Use in the following method to inject the big one to get an artificial break. Inject into the cell wall to leave a large polymer solution under vacuum.
  • the solution method is to divide the bone marrow cells in the bone marrow into a large amount, and then recombine the cells in each of the above to obtain artificial anterior breaks. Anesthetize 0 pieces of Barbie under one piece, and close the gap of each suture phase so as not to suture the outer skin. Mu put 40 units of the powder in L sodium chloride injection, and then inject it into the abdomen. There are 120 large, medium and small materials.
  • the Polyvinyl Chloride Products Co., Ltd. which is evenly divided into Measure 0, and the Polyvinyl Chloride, which is evenly divided into Measure 0, mix with the polymer of polyvinyl chloride 59 in oxygen at a ratio of 59 to 10 in the Jiangxi Institute of Chemical Industry in the above solutions. Is added to the polymer used (NH) 0 of 10 by weight of the material polyvinyl chloride, and a polymer mixed solution containing an aqueous solution and an aqueous solution which are high in the weight of the material polyvinyl chloride. Each material of polymer mixed solution with a thickness of 0.3 on a glass rod.
  • the above tube materials can be used for the cardiovascular system or. It is also possible to make an internal stent rounded to the anastomosis or blood vessel on the wall of the stent.
  • M is dissolved in water and mixed with NHH particles which are polypropylene 1 with high content.
  • the high score will be the blood compatibility at 60C under the flow of ethylene first.
  • outer endothelial cells, smooth cells, cells enhance anticoagulation and strength in the blood tube, its effect is better than blood compatibility.
  • the fat in the solution is tens of thousands of fat, and the fat in the cell will be in the outermost and smooth.
  • the blood of the innermost cell is compatible Material.
  • large gaps of Barbie anesthetized atrium were directly sutured to the upper-conjunct large endothelial cells, cells, and polymer membranes of 4 to the large atrium gap to prevent the outer skin from being sutured.
  • Mu injected the powder of the 40-force parking space into the stomach with mL sodium chloride injection.
  • a mixed aqueous solution with a percent content of force has a high score for mixing.
  • the high score is the blood compatibility obtained by mixing 5 first on ethylene or on the periphery of the plastic etc. on the outside and then on the solution.
  • the poly Shanghai Kehua Chemical Co., Ltd. and Beijing Yongtai Welfare Chemicals Co., Ltd. with an average molecular weight of 30 and 99 are all used in a weight ratio of 1 to 14 in a dioxin cup and mixed.
  • Material implantation Suture the skin. Mu injected the powder of 40 into the leg with L injection and then injected it into the rest. Wood 2 Newly generated materials for 10 rabbits.
  • step 1 To effect 0 large babies were separately anesthetized in the abdominal cavity to produce local ten thousand cells. Connect the blood-compatible materials of step 1 to the extracellular support system and the non-endovascular support system to increase the support system 5.
  • the average molecular weight is 20 force, and the average molecular weight is 8 force.
  • the copolymerization of the same amount of apatite and acetic acid is a polymer material with an amount of 0.
  • the materials on the above can be directly on the materials or on the regenerative absorbability.
  • the above tube materials can be directly connected to the esophagus system, tube system, urinary tract system, tract system, fallopian tube system and neurological system.
  • the following is the effect of the esophagus system
  • Polycarbonate with an average molecular weight of 0 is from Sanan Chemical Co., Ltd. (PL from Yixi Jinfeng Chemical Co., Ltd.) 9 Weight ratio 0 1 is added to the middle of the dimethyl and then added is higher in the material carbon and internal content Water stirring. The solution is supported by 0 copper to form a bracket. Put the above brackets into the mold
  • E aqueous solution then withdraws the support to obtain a blood compatible organ stent.
  • the materials obtained from the above blood-compatible scaffolds are mixed with epidermal growth factor and endothelial cell protein coagulation on the inner surface of the scaffolds, and can be used for organs such as,, and.
  • organs such as,, and.
  • the following is based on the effect of organs 0 big Barbie anesthetized her skin to remove the fat and suture it.
  • a large number of fat cells in fat divided into endothelial cells. 0. 0.1 L in 0.1 mL digestion.
  • the endothelial cells were born in EF ga 5 U pB solution and 10 protein gma U mixed evenly or placed in 5 L 00 UL coagulation PB solution to solidify on the inner surface of the stent.
  • Ethylene Vinyl Acetate Copolymer which is divided equally in the capital of 20, is propelled by Sanyou Co., Ltd., Beijing Baicao Technology Muyou Co., Ltd. 9 to 9%, and is mixed with ethylene vinyl acetate copolymer propylene. Add the high content of the material used in the solution ethylene vinyl acetate copolymer propylene 0 NH 0 force, and the high content of the material ethylene vinyl acetate copolymer propylene 0.00
  • a mixed solution of vinyl is more than 4 in the amount of ethylene in the material and the oxygen content of the polymer material 1 is evenly mixed. Polymer mixing.
  • the polybutyric acid (PHB) which is evenly distributed to the metropolis 20, is composed of copolymers, copolymers, and poly products. South Products Co., Ltd. 29 The ratio of 2 to 1 is higher than 1 for the mixing of materials. Adding in the solution is a high score in the material PHB and by, living and polymerization
  • the copolymerized anticoagulant is NH 0 which is higher than the material 0, and the force added is 0% of PHB.
  • the Gini ge p aqueous solution is added in the form of a well-mixed blood-compatible polymer mixed solution.
  • Each of the above-mentioned blood-compatible polymer mixed solutions was prepared by Zhufa method, and each element material was immersed in water.
  • This material can be used as a substitute for nickel, and can also be used on the upper and lower surfaces of endothelial cells, vascular cells, and adult cells. Below is the physiotherapy effect of esophagus
  • a large number of thousands of cells in the fat group will be divided into endothelial cells, almost cells and thousands of cells. 0.
  • the endothelial cells, smooth cells and thousands of cells of L-digestion are mixed in the L pB solution or on the inner surface of the material.
  • the obvious method of dissolving and dissolving polymer materials with high mechanical properties and anticoagulant materials can uniformly fix the anticoagulant materials in the high score in the material.
  • Conventional methods are used for external use or implantation
  • the organ material overcomes the shortcomings that the effect of the wood is only absorbed on the surface, or the anticoagulant effect of grafting is unclear or very short.
  • the proven blood-compatible materials do not have good anticoagulant properties and delay the anticoagulant orders. They also have good anticoagulant and biological properties to meet the needs of tissue materials for external or internal implant Compatibility, high strength and toughness, and many other performance requirements.
  • the material safety method and the materials used showed that within a short period of time, such as within 3 m 2 3c of rabbits and veins. Internal discomforts that cause inflammation, thousands of packages, thrombosis, hemangioma, calcification and other undesirable effects are promising and multifunctional biomaterials.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A method of preparing a material with blood compatibility comprises dissolving polymer into an organic solvent to form a polymer solution; dissolving an anticoagulant in an inorganic solvent to form an emulsion, slurry or fluid-like mixture; then producing the material with blood compatibility by one of the following means:1) mixing the polymer solution and the emulsion, slurry or fluid-like mixture containing the anticoagulant to make the material with blood compatibility; 2) mixing the polymer solution, a pore forming agent and the emulsion, slurry or fluid-like mixture containing the anticoagulant to make the material with blood compatibility; 3) mixing the polymer solution, a filler and the emulsion, slurry or fluid-like mixture containing the anticoagulant to make the material with blood compatibility. And a material with blood compatibility is prepared by said method. The material has good anticoagulant property, and can meet the requirements of various properties as tissue and organ repair material used in vitro or implanted in vivo such as good anticoagulant property, biocompatibility, high mechanical strength, toughness and the like.

Description

相容性材料及其制各方法 木領域  Compatible materials and methods for making them

本投明涉及 血液相容性材料及其制各方法。  This presentation clearly refers to blood-compatible materials and their preparation methods.

背景 木 Background wood

目前 于 血液相接 的管道系統、 透析系統、 人工 、 人工 支持 系統的 生物材料 存在引起凝血、 血栓等 而一般解決的方法 就是利用表面 , 使其抗凝血性能增強。 一旦材料表面的分于 和 等投生交化 其抗凝血性能則舍下降或消失。 材料在 血液接 很 保持 相 的抗凝血性能 使用 一般只有 小 到  At present, there are biological materials in the blood pipe system, dialysis system, artificial and artificial support systems that cause coagulation and thrombosis. The general solution is to use the surface to enhance its anticoagulant performance. Once the surface of the material is divided into and etc., its anticoagulant properties will drop or disappear. The material is in contact with the blood and maintains the anticoagulant performance of the phase. The use is generally only small to

同日 。 On the same day.

休內有 多 器官系統 、 狹窄等原因需要 或 保持功能 。 以血管 血管由于 脈硬化、 血管老化或破損等原 因而不能正常工作 需要 血管移植。 由于 休器官強烈的 反 、 來源少、 等原因 使人造血管的研究越來越受到重視。 早在 上 40年代 有人就 研究生物休血管的移植 于 只能 塑料管代替血管植入生物休內 由于 重的凝血反 沒有 一例成功。 952 oo hees在 強中偶然 植入生物休內的  There are multiple organ systems, stenosis and other reasons that require or maintain function. Blood vessels Blood vessels cannot work properly due to pulse sclerosis, blood vessel aging or damage, etc. Blood vessel transplantation is required. Due to the strong reaction of organs, few sources, etc., the research of artificial blood vessels has been paid more and more attention. As early as in the last 1940s, some people studied the transplantation of biological blood vessels. Only plastic tubes can be used instead of blood vessels to be implanted in biological blood vessels. Due to heavy coagulation, no case has been successful. 952 oo hees accidentally implanted in the biological rest

上覆蓋有一 內皮細胞 他 假定植入生物休內的鎳 也 同 的現象, 就能避免血液和植入物的直接接 而防止凝血現象的 。 目前 人造血管使用最多的原料是 、 乙烯仟 。 內往大于 的人造 血管一般 或 的 于。 保持 的緊密程度 和 使周圍 附在血管外 向內 血管內 覆蓋 內皮細胞。 內 在6 m的大直往人造血管一般用具有微 的生物惰性材料 乙烯組成, 不需要覆蓋內皮細胞 防止凝血 。 直徑在6 m以下的人造 血管 等原因 床上 沒有得到 。  It is covered with an endothelial cell. He assumes that the same phenomenon as nickel implanted in the body can avoid the direct connection of blood and implants to prevent coagulation. At present, the most used raw material for artificial blood vessels is ethylene vinyl. Artificial blood vessels with an inward greater than or equal to are generally. Maintain the tightness and make the surroundings attached to the outside of the blood vessel and inwardly covered the endothelial cells. The 6-meter-long straight straight artificial blood vessel is generally made of ethylene, which is a biologically inert material that does not need to cover endothelial cells to prevent blood clotting. Artificial blood vessels with diameters under 6 m are not available on the bed.

在 的二十多年 人們一直在探索血管尤其是直往小于5 m血管 的合成 h noka h noka T h T a P e a . ea on OV ab e Pu mo a y a e y au og a s h ough ssue eng nee ng. J ho ac a d ovasc u g 998; 15 36 545 Po yg a n P 合伙羊頭 或 外靜脈 得的混合細胞成分 包括內皮細 胞 E s 、 乎 細胞 細胞 了 羊 替代 物 方法和結果形成 含量較高的新血管。 但P 支撐 5 較弱而且 于僵硬 以承受 較高的休 。 hu 等 hum T ock U H kachJ e a . T ssue e g ee g O au o gou s ao aus ng a e b odeg adab e Po yne . n Tho ac u g In the past twenty years, people have been exploring the synthesis of blood vessels, especially those that are smaller than 5 m, h noka h noka T h T a P ea. Ea on OV ab e Pu mo ayaey au og ash ough ssue eng nee ng. J ho ac ad ovasc ug 998; 15 36 545 Po yg an P. The mixed cell components obtained from the sheep head or the external vein include endothelial cells E s, almost cell-cell sheep replacement methods and result in the formation of new blood vessels with higher content. But P support 5 is weaker and stiff to withstand higher rest. hu et hum T ock UH kachJ ea. T ssue eg ee g O au o gou s ao aus ng aeb odeg adab e Po yne. n Tho ac ug

1999;68 2293 2305 的聚合物 Po y hyd oxya ka oa e PH 的一 即 辛酸 0 的聚 支架材料 了內 有孔 的P 支架阿作力 于細胞的 休 外 孔的PH 支撐的厚度 1.5 的 羊 N k ason等 N k aso LE aoJ bo e a . Fu c o a a e es g o n V o. c e ce  1999; 68 2293 2305 polymer Po y hyd oxya ka oa e PH is a poly scaffold material of 0 octanoic acid. The inner has a porous P scaffold. It works on the PH of the outer pore of the cell. The thickness of the sheep is 1.5. k ason et al. N k aso LE aoJ bo ea. Fu coaae es gon V o. ce ce

1999 284 489 493 以P 支架 合 和E s 灌注系統培育 小口往的可承受一定 力的組 工程血管。 e be g 和Be e be g5 B Be E. b ood Vesse ode Cons uc ed o C u ed  1999 284 489 493 P-stent and E s perfusion system were used to cultivate small-sized engineering vessels that could withstand a certain force. e be g and Be e be g5 B Be E. b ood Vesse ode Cons uc ed o C u ed

vascu a Ce s. c e ce, 98 ; 3 97 400 以 原蛋白 材料 E s及成 細胞 各全生物化組 工程血管。 由于血管 抗凝血性、 強度等的特殊要求 以上 工程血管都存在看一定的 局限 材料本身在不 合內皮細胞 都不 各抗凝血性能 在休內放置0 段 同 仍合引起凝血等 目前 。 vascu a Ce s. c e ce, 98; 3 97 400 The blood vessels were engineered with the original protein material E s and the whole biochemical group of adult cells. Due to the special requirements of anti-coagulation and strength of blood vessels, the above-mentioned engineering blood vessels all have certain limitations. The materials themselves have no anti-coagulant properties in the absence of endothelial cells.

Po y e hane 即 U 是一 含有氨基的聚 材料 各 好的 縫合性、 和 好的成型加工 已被 于 等  Po y e hane or U is a poly-material containing amino groups, each with good stitchability, and good molding processing has been

。 丁酸和3 共聚 Po (3 hyd oxybu y a e co 3 hyd oxyhexa oa e)即 PHBHHx 是一 由細菌合成的 內 在細菌5 內以顆粒狀內含物形式存在。 PHBHHx既 各 以石油化工原料得到的塑 料相似的 塑性 力爭性能 又具各生物可 解性 被 是一 很有前 途的"新型生物可 材料", 倍受人們的重視。 目前PHBHHx已被 于 細胞、 細胞、 軟骨細胞等 的支架材料 ang hao K hen . E ec O Su ace ea en On he b oco pa b y O0 c ob a Po yhyd oxya kanoa es. B o a e a s 2002 3 391 1397 hao K e g he J he . Po yhyd oxya kanoa e (PH ) Sca o ds W h good echa ca P ope es and . Butyric acid and 3 copolymerized Po (3 hyd oxybu yae co 3 hyd oxyhexa oa e), or PHBHHx, is an internal bacterium 5 synthesized by bacteria in the form of granular inclusions. PHBHHx is a promising new type of bio-composite material, which has similar plasticity performance and biodegradability of plastics obtained from petrochemical raw materials. Currently PHBHHx has been used as a scaffold material for cells, cells, chondrocytes, etc. ang hao K hen. E ec O Su ace ea en On he b oco pa by O0 c ob a Po yhyd oxya kanoa es. B oaeas 2002 3 391 1397 hao K eg he J he. Po yhyd oxya kanoa e (PH) Sca o ds W h good echa ca P ope es and

b oco pa b y. B o a e a s 200 4 04 045 , 其力學強度、 生物相容性比其它 PLL PL , PHB等 要好 但 速率很 。 目前 沒有 材料能同 作力 休內大、 小直往管道及器官內管道 系統的材料 尤其是作力血管或 器官的管道系統所需求的良好的抗凝 血性、 較高的 強度和韌性、 速率 新生組 速率相匹配的多 方面性能的 材料。 B oco pa b y. B o a e a s 200 4 04 045, its mechanical strength and biocompatibility are better than other PLL PL, PHB, etc. but the rate is very high. At present, there is no material that can be used as the material for the large and small straight pipelines and the pipeline system in the organ, especially the pipeline system for the force vessel or organ. Group rate matches the multi-faceted performance material.

公升  Liter

本 的目的是提供 血液相容性材料及其制各方法。  The purpose of this book is to provide blood compatible materials and their preparation methods.

本 提供的 各血液相容性材料的方法 是將 于量力 00力的 高分子材料 于有 中 成反 百分含量力0. 20 的高分于 溶液 將抗凝血材料用 溶解 形成乳狀、 漿狀或 休 然 按照下述 或2 或3 的方法得到血液相容性材料  The method of each blood-compatible material provided in this book is to convert the polymer material with a force of 00 force to a percentage of the force of 0%. A high score of 20 is in the solution. Dissolve the anticoagulant material to form a milky, slurry, or still. Follow the method described below or 2 or 3 to obtain a blood compatible material

將 高分子 和 抗凝血材料乳狀、 漿狀或 休 混 合 的休外 材料或休內植入的組 器官 材料 即 血液相容 性材料  Extra-organic materials mixed with polymers and anticoagulant materials in milky, pasty, or interstitial materials

2 將 高分于溶液、 抗凝血材料乳狀、 漿狀或 休 物和 混合 休外 材料或休內植入的 器官 材料 除去 得到血液相容性材料 是 高分子材料 量的20 或20 以下  2 Remove the blood-compatible material that is high in the solution, the anti-coagulant material milky, paste-like, or mixed with the rest material or the implanted organ material.

3 將 高分子溶液、 所述抗凝血材料乳狀、 漿狀或 休 物和填充 混合 休外 材料或休內植入的 器官 材料 即 血 液相容性材料 填充 是 高分子材料 量的的20%或20 以 或2 或3 的抗凝血材料是 高分子材料原量 的0.00 0  3 Fill the polymer solution, the milky, pasty or anti-coagulant material and the mixed extra-rest material or the organ material implanted within the rest, that is, the blood-compatible material is 20% of the amount of the polymer material Or 20 to 2 or 3 anticoagulant material is the original amount of polymer material 0.00 0

民用高分子材料力 、 均有 的共聚 、 內 的共聚 也 聚合物 、 乙烯碳酸 、 碳酸 、 丙烯 、 芳香 、 3 丁酸和3 共聚 、 乳酸、 內 乳酸 共聚 、 丁酸 、 、 、 、 氧乙烯、 乙烯 醋酸乙烯共聚 、 、 、 聚氯乙烯、 聚丙烯 、 、 丙烯 、 碳酸 、 、 、 、 或它們的衍生物醋酸仟 、 、 聚氯乙烯、 二甲 的共聚 、 有 住及聚 的共聚 、 、 、 乙烯 中的一 或 的 混合物 抗凝血生物材料力 、 抗凝血 、 、 腎上腺素、 、 、 阿 、 消炎 、 它 、 、 基化硫酸 化 、 水 、 抑制 或 氧 抑制 蔗糖、 右旋 、 Na NHH 、 (NH 0、 Na N H ,或Na (NH) 0的混合物 所述的填充物力 磷灰石 磷酸 鈣。 有 4二氧 、 、 、 二氧 Civil polymer material strength, all copolymerization, inner copolymerization also polymer, ethylene carbonic acid, carbonic acid, propylene, aromatic, 3 butyric acid and 3 copolymerization, Lactic acid, internal lactic acid copolymer, butyric acid, ethoxyl, ethylene oxide, ethylene vinyl acetate copolymer, ethene, polyvinyl chloride, polypropylene, propylene, carbonic acid, ethene, ethene acetate, ethene acetate, ethene, polyvinyl chloride, Dimethicone copolymerization, copolymerization of living and polymerization, ethylene, one or a mixture of ethylene, anticoagulant biomaterials, anticoagulant, epinephrine, thiophene, anti-inflammatory, anti-inflammatory, it, basified sulfate, Water, inhibitory or oxygen-inhibiting sucrose, d-rotation, Na NHH, (NH 0, Na NH, or Na (NH) 0 mixture as described in the filling force apatite calcium phosphate. There are 4 dioxins,,, dioxins

、 氫 、 二甲 或二甲 其中 或 以上混 合 。  , Hydrogen, dimethyl, or dimethyl or a mixture of or more.

力水、 生理 水、 磷酸 、 溶液或 水。 混合物用 、 、 、 、 快速成形或 法制各成材料均一或 的薄膜 、 、 、 、 狀或阿 的血液相溶性的休外 材料或休內植入的 器官 材 料。  Forced water, physiological water, phosphoric acid, solution or water. The mixture is made of thin films,,,,, or blood-soluble extracorporeal materials or organ materials implanted within the rest of the time by the rapid prototyping or method of making the material uniform or.

用水或 水溶液浸泡除去。  Remove with water or aqueous solution.

抗凝血材料 如下方法她 將抗凝血材料用 溶解, 在溶解 的抗凝血材料溶液中加入是抗凝血材料的 量的0.0 的 反 反 用水或 水溶液浸泡 除去  Anticoagulant material: Dissolve the anticoagulant material with the following method, add the anti-coagulant material to the dissolved anticoagulant material solution by the amount of 0.0.

的 N N 碳 碳 The N N carbon carbon

2 N 磺酸系統、 、 多 或吉尼 。  2 N sulfonic acid system,, poly, or gini.

所述 狀或阿 狀血液相容性材料 其內外表面 合內 、 乎 細胞、 仟 細胞、 細胞、 細胞、 胰島細胞或心肌細胞或 將 細胞 、 自 凝血 混合 , 注射器注入管道系統 形 成的 中 各 器官 材料。 在 或注射 細胞的同 在 材料表面或內部 合 、 、 生畏因子或血清。 本 所提供的上 的 各方法制各的血液相容性生物材料也 于本 的保 。 The inner or outer surface of the shape-like or arhat-like blood-compatible material is composed of cells, thousands of cells, cells, cells, islet cells or cardiomyocytes, or cells and self-coagulated blood are mixed, and the syringe is injected into the organ materials formed by the pipeline system . Inject or inject the cells on the surface or inside of the material, cytophobia factor or serum. The blood-compatible biomaterials prepared by the above methods are also covered by this book.

的最佳方式  The best way

下 中的百分含量 如 特別 均力 百分含量。  The percentage content in the following is as the percentage of the special uniform force.

下述 中的方法 如 特別 均力 方法。  The method in the following is a special uniform force method.

本 所提供的一 血液相容性生物材料。 材料由 高分于材料 和抗凝血生物材料 溶解混合 加入 或填充 、 、 、 快速成形 或 竺法制各 薄膜 、 、 中空仟 、 、 狀或阿 的休外用的血液相溶性生物材料或休 內植入的組 器官 材料, 其中抗凝血生物材料 高分子材料的 百分比 0.00 0 的 或填充 高分于材料的 百分比 0 20 。 所述的 高分子材料 This is a blood-compatible biomaterial. The material is composed of materials and anticoagulant biomaterials that are dissolved and mixed into or filled with,,,, rapid prototyping or Zhufa made of thin films, hollow hollow,, shape or Axius for external use of blood-compatible biomaterials or implantation The organ material of the group, wherein the percentage of anticoagulant biomaterial polymer material is 0.000 or the percentage of filling is higher than the material percentage 0 20. The polymer material

Po yu e hane 、 內 的共聚 P LPE 即 PU 、 3 丁酸和3 共聚 (PHBHHx)、 乙烯碳酸 、 乳酸(PLL )、 內 (P L)、 乳酸 共聚 (PL )、 丁酸 (PHB) Po yu e hane, internal copolymerization L LPE namely PU, 3 butyric acid and 3 copolymerization (PHBHHx), ethylene carbonate, lactic acid (PLL), internal (PL), lactic acid copolymerization (PL), butyric acid (PHB)

(PHB )、 、 有 的共聚 、 、 氧乙烯、 乙烯 醋酸乙烯共聚 、 、 、 聚氯乙烯、 乙烯 、 聚丙烯 、 、 丙烯 、 碳酸 、 、 、 、 或它們的衍生物醋酸 、 、 聚氯乙烯、 (PHB),, some copolymers,, ethylene oxide, ethylene, vinyl acetate copolymer,,, polyvinyl chloride, ethylene, polypropylene, propylene, carbonic acid,,,, or their derivatives acetic acid, polyvinyl chloride,

(Po ye e e ha e ea) (Po y e a e ea) 占有 及聚 的共聚 、 乙烯 、 有 住及聚 的共聚 、 二甲 (po yd e hy s oxane)  (Po ye e e ha e ea) (Po y e a e ea) Possession and polymerization copolymerization, ethylene, living and polymerization copolymerization, po yd e hy s oxane

(po ye he e ha eu ea)的共聚物中的一 或 的混合物 的抗 凝血生物材料 、 抗凝血 、 、 腎上腺素、 、 、 、 阿 、 消炎 基化硫酸 化 、 水 、 抑制 或 氧 抑制 。 所述的 蔗糖、 右旋 、 Na NHH (NH) Na NHH 或Na (NH4) 的混合物 所述的 填充 磷灰石、 磷酸鈣 (po ye he e ha eu ea) one or a mixture of copolymers of anticoagulant biomaterials, anticoagulant, epinephrine,,,,, a, anti-inflammatory sulfation, water, inhibition or oxygen inhibition . The said mixture of sucrose, dextrose, Na NHH (NH) Na NHH or Na (NH4) The filled apatite, calcium phosphate

宴 血液相容性不 的 各和 和  Feast of blood compatibility

、 血液相容性不 的 各  , Each with different blood compatibility

將 均分子量力 0 的聚 內 聚合物 P LPE 即 U 按照文 , P LPE PU 物的研究 大 2003中 的方法制各 于 0 L的 4二氧 , 成派 9 的P LPE 溶液。 在 燒杯中 0. 加入 nL 萬于水溶解 溶液。 將上 P LPE 溶液 按照休 比 000 的比例混合 充分 均勻 高分于混合 。 The P LPE with an average molecular weight of 0 is U According to the article, the method of P LPE PU material research in 2003 is to prepare 0 L of 4 dioxins to form 9 P LPE solutions. 0 in the beaker. Add nL to dissolve the solution in water. The upper P LPE solution was mixed according to the ratio of Huby 000, fully and evenly divided into the mixture.

在一介多 支撐 上 高分予混合 先鋒 介快速 以形成一致密 然 將 0. 水溶液中 使 尚未 的一 化 形成 面具有多 的不 。  High scores on a multi-media support to the mixed Pioneer media quickly to form a consistent consistency will be 0. In the aqueous solution, there are many unformed surfaces.

血液相容性不 的 物安  Blood incompatibility

步驟 各的不 也 各向 可用做 透析 、 、 血漿 萬 生物反 內細胞支持 等生物材料。 也可作力 休 器官 的 其上下表面 合內皮細胞、 細胞或乎 細胞 可用做 、 血管等 。 下面 以血管 其效果  Each step can be used as a biological material for dialysis, plasma and bio-intracellular support. It can also be used as an endothelial cell, cell or cell on the upper and lower surfaces of the organ, which can be used as a blood vessel, etc. Below is the effect of blood vessels

將 0只普通 狗分別 巴比 麻醉 腹腔 將 靜脈 一直往 3 m的缺口 將 直徑 8 m的步驟 方法制各的不 Anesthetize 0 ordinary dogs with Barbie anesthetize the abdominal cavity, keep the vein all the way to a gap of 3 m, and follow the steps of 8 m in diameter.

6 0 縫合 在缺口上 多 朝外 以不 將 外皮縫合。 木 將40 的 粉末 于 L氯化 注射 中 然 腹部注入休內。 10只狗的內皮細胞等 滿缺口 不 你 逐漸 靜脈血管 完全 。 6 0 Stitch the outer side of the gap so as not to sew the skin. Mu injected the powder of 40 in L chloride injection into the abdomen. The endothelial cells of 10 dogs, etc. are full of gaps and you gradually become venous blood vessels completely.

2 血液相容性管的 各及效果  2 The effects and effects of blood compatibility tubes

、 血液相容性管的 各  , Each of blood compatibility tubes

將29 均分予量力 的聚 濟南 材料有限公司 于10 L 4 氧 杯中 29 m 的聚 溶液。 在 燒 杯中 0.000比 加入 L . 醋酸使其溶解 溶液, 再 加入是 重量的0. 的N N 二林 碳 由碳 Divide 29 evenly-weighted poly Jinan Materials Co., Ltd. in a 10 L 4 oxygen cup with a 29 m poly solution. In the beaker, add L. acetic acid to dissolve the solution at a ratio of 0.00, then add 0. 0 by weight. N N Erlin carbon by carbon

E 、 並 NH 2 N 磺酸 E 按照 4 2 的 比混合 再 上 溶液充分 均勻 高分于 混合溶液。  E, and NH 2 N sulfonic acid E was mixed according to the ratio of 4 2 and then the solution was fully uniform and highly divided into the mixed solution.

在一根 上 混合高分子溶液 形成一根管 然 將 在大量 百分含量力0. 水溶液中浸泡使其 萬 除去 系統, 血液相容性 。 Mixing a polymer solution on one to form a tube will result in a large percentage content of 0. Soak in water Million removal system, blood compatibility.

2、 相容性管的  2. Compatibility tube

步驟1 各的 相容性 可用于 休各 的 也可在 其上下表面 合內皮細胞、 乎 細胞及成 用做 、  Step 1 The compatibility of each can be used for each of them. It can also be combined with endothelial cells, cells and functions on its upper and lower surfaces.

、 血管、 等的替代物。 下面 以 的 的  , Blood vessels, etc. Below of

其效果  Its effect

將 0只兔子 新西 大 自 分別 巴比 麻醉 大腿內側 將 1.2 C 的缺口 將 直往 2 的步 驟 的方法制各的血液相容性管用 合 將 缺口兩端縫合 內 將外皮縫合。 木 將40力車位的 粉末 于 L氯化 注射 中 然 大腿肌肉內注入休內。 0只兔于的受損  0 rabbits were anaesthetized by Barbie anesthesia from the inside of the thigh. The 1.2 C gap will be straightened to the step 2 to make each blood compatible tube. The two ends of the gap are sutured and the outer skin is sutured. Mu injects the powder of the 40-force parking space into the chlorinated injection, and then injects it into the thigh muscles. 0 rabbits damaged

缺口 材料半年 逐漸 完全 。 The gap material is gradually completed in half a year.

3 血液相容性 材料的 各及效果  3 Blood compatibility materials and their effects

、 血液相容性 材料的 各 , Each of the blood-compatible materials

9 均分子量力 0 3 丁酸和3 酸的共聚 (PHBHHx) a ou L any B o ech o pany a gdo g h a 照 文獻 Z yang P u he . e abo c e g ee g o P od c o O Copo yes e s Co s s g O 3 hyd oxyb y a e a d 3 hyd oxyhexa oa e by eco b nan ae o aonas 9 Average molecular weight 0 3 Copolymerization of butyric acid and 3 acids (PHBHHx) a ou L any B o ech o pany a gdo gha according to literature Z yang P u he. E abo ceg ee go P od co O Copo yes es Co ssg O 3 hyd oxyb yaead 3 hyd oxyhexa oa e by eco b nan ae o aonas

hyd oph aha bo g phb a d phbB ge es. ac o o B osc hyd oph aha bo g phb a d phbB ge es. ac o o B osc

2004 4 255 26 中 的方法制各 于 00 mL 中6 C下回流 h 然 將 均分子量力 0 的PHBHHx 溶液萬 500 g 2 n 以除去不溶性顆粒。 往 中加入 得到 93 的的PHBHHx 。 將 化 PHBHHx 均分于量力8 的聚 9 比 0 于 氯仿中 依 9 m 的聚合物溶液。 然 將 0 L的聚合物溶液 5 L的 9 的 水溶液 血液相容性高分子混合 。 將 溶液倒在平板上 3 的 材 料。 The method in 2004 4 255 26 was prepared by refluxing in 00 mL at 6 C. Then, the PHBHHx solution with an average molecular weight of 0 was 500 g 2 n to remove insoluble particles. Add PHBHHx of 93 to it. The PHBHHx is evenly divided into a poly- 9 of 0 to a force of 8 in a polymer solution of 9 m in chloroform. Then, 0 L of polymer solution, 5 L of 9 aqueous solution of blood compatible polymers are mixed. Pour the solution onto the plate 3 of material.

血液相容性 材料的  Blood compatibility

由此 各的 材料可用于心血管系統的 或 。 也可用于血管 吻合或血管 的內支架。 下面 以心房 的 物安 其效果 將 0只兔于 新西 大 分別 巴比 麻醉 胸腔 將 心房 一直徑 m的缺口 將 直往 4 的步驟 各的 材料用8 0 合我 在缺口上 多 朝外 以不 As a result, the various materials can be used in the cardiovascular system. Can also be used for blood vessels Anastomotic or vascular stent. The following is based on the effect of the atrium on the safety of 0 rabbits in New West University, respectively.

將外皮縫合。 木 將40 單位的 粉末 于 L氯化 注 射 中 然 腹部注入休內。 表明 0只兔子的心房 完全 材料 。 Suture the skin. Mu injected 40 units of powder into L chloride and injected it into the abdomen. It shows that the atrium of 0 rabbits is completely material.

4 血液相容性薄膜材料的 各及效果  4 Each and effect of blood-compatible film materials

、 血液相容性薄膜材料的 各  , Each of the blood-compatible film materials

將 均分子量力20力的29 已內 的共聚 (P LPE ) 按照文獻 , P LPE PU 物的研究 大  According to the literature, the research on P LPE PU materials is based on the copolymerization (P LPE) with an average molecular weight of 20 and 29 forces.

2003中描述的方法制各 0.29 均分于量力 0 的乳酸 共聚 (PL 生物科技有限公司) 于 0 mL 4二氧 杯中 充分攪拌 除去 然 在溶液中加入是所用高分于材料 LPE 和PL 重量的20 的 Na 和是所用高分于材料 P LPE 和 PL 恩重量的 的 于0.5 L . 中 溶液 再加入 是P LPE PL 恩重量的0. 的 依 3 的 水溶液 然 倒 在 乙烯乎 上流 薄膜。 The method described in 2003 prepared 0.29 lactic acid copolymer (PL Biotechnology Co., Ltd.), which was evenly divided into 0. The weight of Na and the weight of 20 are the high scores used in the materials P LPE and PL. The weight is 0.5 L. The solution is added to the weight of P LPE PL 0. The aqueous solution of Yi 3 was poured on the upper film of ethylene.

將上 得的薄膜在 的 水溶液中浸泡 除去 及交 中 千 得 薄膜材料。  Soak the obtained film in the aqueous solution to remove and transfer the film material.

2、 血液相容性薄膜材料的  2. Blood compatible film materials

步驟 各的 鎳 薄膜材料用于心房的 。  Step The nickel thin film material is used for atrium.

將 0只新西 大 白兔分別 巴比 麻醉 她外皮 取 出其中部分 。 或 解法分萬骨髓中的骨髓 細胞 大量 合在上述 各的血液相容性 材料上。 將 兔子分別 巴 比 麻醉 心房 一直徑 的缺口 將 直徑 4 的上 合自休骨髓于細胞的 材料用8 0 縫合哉 在 兔于心房缺 口上 以不 將外皮縫合。 木 將40 的 粉末 于 L氯化 注射 中 然 腹部注入休內。 12 10只兔于 完全 材料 。 2 將步驟 0 New Zealand white rabbits were Barbie anesthetized and her skin was removed. Or, the bone marrow cells in the bone marrow are divided into a large number of the above-mentioned blood-compatible materials. The rabbits were anesthetized with a barium anesthesia with a diameter of one atrium, and the material with a diameter of 4 that was combined with the self-resting bone marrow cells was sutured with 80 ° to the rabbit at the atrial gap so as not to suture the outer skin. Mu injected the powder of 40 into the abdomen during L chloride injection. 12 10 rabbits on the complete material. 2 step

的 。 of .

將 0只兔子 新西 大 分別 巴比 麻醉 腹腔 將 其中樞神 3 的缺口, 將 片面 4 的 合骨髓 細胞的銅鎳 薄膜材料用8 0 縫合哉 在缺口外 將外皮 縫合。 木 將40 羊 的 粉末 于 mL氯化 注射 中 然 腹部注入休內。 0只兔子的中樞神 完全 園材 料 。 0 rabbits of New Zealand University were anesthetized with Barbie anesthetized abdominal cavity, the gap of the central nerve 3 was cut, and the single-sided copper-nickel thin film material of bone marrow cells was sutured with 80 sutures and the outer skin was sutured outside the gap. Mu injected the powder of 40 sheep in mL of chlorinated injection and then injected it into the abdomen. The central god of 0 rabbits is completely garden material.

5 血液相容性阿 高分于支架材料的 各及效果 血液相容性阿 高分予支架材料的 各  5 Hemocompatibility scores high for each stent material and effects Hemocompatibility scores high for each stent material

將 均分于量力30力的聚 京京 制品有限公司 均分子量力20力的聚乳酸(PLL 生物科技有限公司) 9 比 0 于 0 L二氧 中 高分子混合溶液 再加入是所用高分于材料 和PLL 重量 的 0 于 L . 水中 和是所用高分子材料 和PLL 重量 0 的Na 充分攪拌 除去 高分于材料混合 休。 將高 分于材料混合 休 在 乙烯 上 血液相容性高分于薄膜 以萬 的原理 通 快速成型 在 上 高分于薄膜上 各 阿 高分予支架材料。  Polylactic acid (PLL Biotechnology Co., Ltd.) with an average molecular weight of 20 force and polylactic acid (PLL Biotechnology Co., Ltd.) with an average molecular weight of 30 force and a force of 30 force is added to the material and The PLL weight is 0 in L. The neutralization in water is the polymer material used and the PLL weight 0 in Na is fully stirred to remove the high score in the material mixing. Mix high scores with materials and rest on ethylene. Hemocompatibility is high on films. Ten thousand principles through rapid prototyping on the high scores on the film. Each high score for the stent material.

血液相容性阿 高分予支架材料的  Blood compatibility A high score for stent material

在支架材料的阿 上按照如下方法 合兔心肌細胞 0只新西 大 自兔分別 巴比 麻醉 她外皮 取出其中脂肪 將 縫合 。 法分萬脂肪組鎳 的脂肪 細胞 大量 將 心肌細胞。 將0. L消化萬 的心肌細胞 溶解 在 L PB 溶液中 然 在血液相容性高分子薄膜上。 將上 0只 兔于分別 巴比 麻醉 分別將 合了 心肌細胞的一介 在 心房洞口。 木 將20 的 粉末 于 L氯化鈉注射 中 然 腹部注入 內。 木 2 0只兔于心房 好 材料 2 將 0只兔于 新西 大 分別 巴比 麻醉 將 心房 一直往 l 缺口 將 直往 4 m 的上述方法 合心肌細胞的高分于薄膜 8 0 合 在缺口上 以不 On the scaffold material, the rabbit cardiomyocytes were combined with 0 neo-Xinda rabbits from the skin, and the outer skin of each rabbit was anesthetized to remove the fat and suture. A large amount of nickel fat cells in the fat group will convert cardiomyocytes. 0. L-digested cardiomyocytes are dissolved in L PB solution and then on the blood-compatible polymer film. The above 0 rabbits were anesthetized under Barbie anesthesia, respectively, and the one with myocardial cells was inserted in the atrium opening. Mu injected 20 powder into the abdomen in L sodium chloride injection. Wood 2 0 rabbits in the atrium good material 2 0 rabbits were anesthetized in New Zealand University Place the atrium all the way to the notch. The above method straight to 4 m is combined with the high score of cardiomyocytes in the membrane 80.

將外皮縫合。 木 將40 單位的 粉末 于 L氯化鈉 注射 中 然 腹部注入休內。 六十月 0只兔子的心房 完全  Suture the skin. Mu will inject 40 units of powder into L sodium chloride injection and then abdomen into the stomach. Sixty October 0 rabbit's atrium completely

材料 。 Materials.

6 血液相容性支架系統材料的 各及效果  6 Materials and effects of blood compatible stent system

1、 血液相容性支架系統材料的 各  1. The materials of the blood compatible stent system

在 均分于量力 0 的聚乙烯碳酸 市三安化工有限公司 均分予量力 10力的聚乙烯 PET 化工有限公司 乙烯碳酸 和 乙烯的 比 2 的 4 二氧 混合溶液中, 加入是所用 高分子材料 乙烯碳酸 和 乙烯 恩重量的 的腎上腺素 磷酸 溶解 及是高分子材料 乙烯碳酸 和 乙烯 恩重量 0 的NHH 高分于混合溶液。 以萬 的原理 快速成型 低溫下將 高分 于混合溶液 內部 多分支管道的、 的支架系統 。 在 中按照如下方法注入大 得到人工 前休。 注入細胞 壁上 留下大 可在 真空 下 上述高分子溶液。  Polyethylene carbonate, which is evenly divided into the quantity 0, and Sanan Chemical Co., Ltd. is equally divided into the quantity 10, the strength of the polyethylene PET Chemical Co., Ltd., the ratio of ethylene carbonate to ethylene, and the ratio of 2 to 4 dioxins. Ethylene carbonate and ethene weight adrenaline phosphate dissolve and the high molecular weight ethene carbonate and ethene weight 0 NHH in the mixed solution. The rapid prototyping principle is based on the principle of 10,000, and it will be highly divided into the multi-branch piping and support system inside the mixed solution at low temperature. Use in the following method to inject the big one to get an artificial break. Inject into the cell wall to leave a large polymer solution under vacuum.

2、 血液相容性支架系統材料 物安  2. Material of blood compatible stent system

物安 將 0只大 分別 巴比 麻醉  Wu'an will be 0 big each

她外皮 取出其中部分 。 解法分 骨髓中的骨髓 細胞 大量 將 細胞再 合在上述 各的 中得到人工 前休。 將 0只大 分別 巴比 麻醉 下一片, 將上述 各 縫合相 的 缺口上 以不 將外皮縫合。 木 將40 單位的 粉末 于 L氯化鈉注射 中, 然 腹部注入休內。 12 0只大 中 小 材料均未 。  She took out part of her skin. The solution method is to divide the bone marrow cells in the bone marrow into a large amount, and then recombine the cells in each of the above to obtain artificial anterior breaks. Anesthetize 0 pieces of Barbie under one piece, and close the gap of each suture phase so as not to suture the outer skin. Mu put 40 units of the powder in L sodium chloride injection, and then inject it into the abdomen. There are 120 large, medium and small materials.

血液相容性 狀或支架材料的 各及效果  Blood compatibility characteristics or stent materials and their effects

、 血液相容性 狀或支架材料的 各  , Blood compatibility or stent material

將 均分于量力 0 的聚 自 京京 制品有限公 司 均分于量力 0 的聚氯乙烯 自 江省化工研究院 59 比 10 于 氧 中 和聚氯乙烯 59 的聚合物混合 , 在上述 各的溶液中加入是所用高分子 材料 聚氯乙烯 重量的10 的(NH) 0, 及含有是所 用高分于材料 聚氯乙烯 恩重量 的阿 水溶液 阿 水溶液的 高分子混合溶液。 在玻璃 棒上 厚度 0.3 的高分子混合溶液 各 材料。The Polyvinyl Chloride Products Co., Ltd., which is evenly divided into Measure 0, and the Polyvinyl Chloride, which is evenly divided into Measure 0, mix with the polymer of polyvinyl chloride 59 in oxygen at a ratio of 59 to 10 in the Jiangxi Institute of Chemical Industry in the above solutions. Is added to the polymer used (NH) 0 of 10 by weight of the material polyvinyl chloride, and a polymer mixed solution containing an aqueous solution and an aqueous solution which are high in the weight of the material polyvinyl chloride. Each material of polymer mixed solution with a thickness of 0.3 on a glass rod.

2、 血液相容性 狀或支架材料的  2. Blood compatibility or stent material

上 各的管 材料可用于心血管系統的 或 。 也可在支架壁 上打圓形 于血管吻合或血管 的內支架。 下面 以  The above tube materials can be used for the cardiovascular system or. It is also possible to make an internal stent rounded to the anastomosis or blood vessel on the wall of the stent. Below

其效果  Its effect

將 0只兔于 新西 大 自 分別 巴比 麻醉 大腿內側 將 一直往 .2 Cm的缺口 將 直往 2 m 的管 材料用 縫合 將 兩端縫合 管內西側 將外皮縫合。 木 將40 的 粉末 于 L氯化 注射 中, 然 大腿肌肉內 注入休內。 一年 0只兔于的神 缺口 材料  0 rabbits were anaesthetized on the inner thighs of the New Zealand University from Barbie. A 2 cm gap is used to sew the tube material straight to 2 m with sutures and sew the ends to the west side of the tube. Mu took the powder of 40 in L chloride injection, and then injected it into the thigh muscle. One year, 0 rabbits, god, notch, material

完全 。 Completely.

8 血液相容性 的 各及效果  8 Each and every effect of blood compatibility

、 血液相容性 的 各  , Each of blood compatibility

將 均分于 都 的聚 聚丙烯 0 1的 比 于 MF 中 聚丙烯 的高分子溶 液。 在 高分子溶液中加入是 聚丙烯 的 The polymer solution of polypropylene divided evenly by the ratio of 1: 1 to the polypropylene in MF. Polypropylene is added to the polymer solution

. M 水溶解 和是 聚丙烯 1 的NHH 顆粒 高 分予混合 。 將 高分于混合 先在 乙烯 上流 直往 的 60C下將 血液相容性 。  M is dissolved in water and mixed with NHH particles which are polypropylene 1 with high content. The high score will be the blood compatibility at 60C under the flow of ethylene first.

血液相容性 的  Blood compatibility

分別在上述 各的血液相容性 的內外 或管內、 外 內 皮細胞、 平滑 細胞、 細胞 增強 抗凝血性和 強度 于血 管 其效果比 血液相容性 更好。  Respectively inside and outside of the above blood compatibility or inside the tube, outer endothelial cells, smooth cells, cells enhance anticoagulation and strength in the blood tube, its effect is better than blood compatibility.

將 R大 分別 巴比 麻醉 她外 皮 取出其中脂肪 將 合 。 解法分萬脂肪 中 的脂肪于細胞 大量 將 內 在最外 、 平滑  Barbie anesthetizes her skin and removes the fat from it. The fat in the solution is tens of thousands of fat, and the fat in the cell will be in the outermost and smooth.

中同 、 細胞 最內 合在上 各的血液相容 材料上。 將 0只大 分別 巴比 麻醉 心房 直往 的缺口 將 直往 4 的上 合相 大 內皮細 胞、 乎 細胞、 細胞的高分子薄膜分別 8 0 縫合哉 在 大 心房缺口上 以不 將外皮縫合。 木 將40力車位的 粉末 于 mL氯化鈉注射 中 然 腹部注入休內。In the same, the blood of the innermost cell is compatible Material. 0 large gaps of Barbie anesthetized atrium were directly sutured to the upper-conjunct large endothelial cells, cells, and polymer membranes of 4 to the large atrium gap to prevent the outer skin from being sutured. Mu injected the powder of the 40-force parking space into the stomach with mL sodium chloride injection.

10只大 心房 完全 血液相容性 材料 。 10 large atria with complete blood compatibility materials.

9 血液相容性 的 各及效果  9 Blood compatibility and effects

1、 血液相容性 的 各  1. Blood compatibility

將 均分于量力 10 的聚丙烯 塑化有限公司  Will be evenly divided into 10 Polypropylene Plastics Co., Ltd.

州市 貿易有限公司 比1 于 氯仿中 將 29 青島 生物工程有限公司 于 氯乙 和 氯乙 氯乙 和 氯乙 的 比 3.6 6.5 的混合溶液中 分別 高 分子溶液 然 將 溶液混合起 然 加入是混合 休 的 百 分含量力 的 水溶液 高分于混合 。 將 高分于混合5 先在 乙烯 上 或塑料 外圍 等 在外側再 或 溶液 得的血液相容性 。  City Trading Co., Ltd. 1 in chloroform, 29 Qingdao Biological Engineering Co., Ltd. in a mixed solution of chloroethyl and chloroethyl chloride and chloroethyl ratio of 3.6 6.5, respectively, a polymer solution and then the solution was mixed and added A mixed aqueous solution with a percent content of force has a high score for mixing. The high score is the blood compatibility obtained by mixing 5 first on ethylene or on the periphery of the plastic etc. on the outside and then on the solution.

血液相容性 的 物安  Blood compatibility

上 各的血液相容性 可用作止血材料或 材料。 下 面 以 其效果 The blood compatibility of the above can be used as a hemostatic material or material. Below with its effect

0 將 0只大 5D 分別 20 麻醉 將 背部 刀片 刮破 形成 3X3 的 將步驟 1 各的血液相容性 合 上。 木 將20 的 粉末 于 mL氯化鈉注射 中 然 背部注入休內。 6 0只大 的 材料 。0 Will be 0 big 5D separately 20 anesthetize scrape the back blade to form 3X3. Put the blood compatibility of step 1 together. Mu inject 20% of the powder in mL of sodium chloride injection and then inject it into the back. 60 large materials.

0 血液相容性 材料的 各及效果 0 Blood compatibility materials and their effects

1、 血液相容性 材料的 各  1. Blood compatibility materials

將 均分子量都 30 化 99 的聚 上海 此化 有限公司 和 北京 永泰福利化工 59, 10 的重 量比加入1 有 1 4二氧 杯中 和 混合 。 將所用高分子材料 和 量的0 的 The poly Shanghai Kehua Chemical Co., Ltd. and Beijing Yongtai Welfare Chemicals Co., Ltd. with an average molecular weight of 30 and 99 are all used in a weight ratio of 1 to 14 in a dioxin cup and mixed. The polymer material used and the amount of 0

0 南 有限責任公司 所用高分子材料 和 量的gn 的 磷灰石、 所用高分予材料 和 反量的 g.n 的碳 ED 2 醋酸溶液溶解 加入到上 0 The polymer materials and materials used by South Co., Ltd. The amount of gn apatite, the high-weight pre-material used and the reverse amount of gn carbon ED 2 acetic acid solution are added to the

和 混合溶液中。  And mixed solution.

將溶液倒在容器中 2 C 、 得到 3 m的 材料。 大量水泡 得到的血液相容性 材料。  Pour the solution into the container with 2 C to obtain 3 m of material. A large number of blisters to obtain blood-compatible materials.

2、 血液相容性 材料的 、 再生的可吸收性 。 將0. 的 形成蛋白 BMP 2 于 的 醋 酸溶液中 將步驟 中 各的血液相容性 材料放在 溶液中浸泡6小 吸附 形成蛋白 在 房1 的PHBHHx 4二氧 溶液 將 或 得到 材料。 其中PHBHHx 0 . m。 材料 軟組 接 的致密 具有良好的細胞 萬功能 或 接 的多 到 坎的作用 細胞 合。 下面 以 材料 物安 其效果  2. Blood compatibility, regenerative absorbability. 0. Form the protein BMP 2 in the acetic acid solution. Place the blood compatibility materials in the step in the solution and soak for 6 hours. Adsorb the protein forming PHBHHx 4 dioxin solution in room 1 to obtain the material. Among them PHBHHx 0. m. The soft-connected material is dense and has good cell function or connects more than a stumbling cell. Below is the material and its effect

將 0只兔子 新西 大 自 分別 巴比 麻醉 外 將其中 .2 Cm的 , 將 1 直往 3 mm的相  0 rabbits from New West University will be anesthetized separately from Barbie. 2 Cm, move 1 straight towards the 3 mm phase

材料植入 縫合外皮。 木 將40 的 粉末 于 L 注射 中 然 腿部注入休內。 木 2 10只兔子的新 生成 材料 。 Material implantation Suture the skin. Mu injected the powder of 40 into the leg with L injection and then injected it into the rest. Wood 2 Newly generated materials for 10 rabbits.

11 相容性 材料的 各及效果  11 Compatibility of materials and their effects

、 血液相容性 材料的 各  , Each of the blood-compatible materials

將 均分子量都 1 化 98.2 純度 的聚 南京 工程塑料 有限公司 和 仟 天津市同 化工 2的 比加入到 有 二甲基正 中 和 素的 合溶液 然 加入是 和 0 0 的 它 Add Poly Nanjing Engineering Plastics Co., Ltd. and Thousand Tianjin with the average molecular weight of 98.2 purity to the chemical industry 2 and add it to the mixed solution with dimethyl n-neutralizer. Then add it to 0 and 0.

d azo e 攪拌均勻 合溶液 將溶液倒在玻璃器皿中 d azo e stir well to mix the solution pour the solution into glassware

4C下 、 得到血液相容性 材料。 由此得到的 材料 可直接 于休外人工 、 支持系統。  Under 4C, blood compatible materials are obtained. The materials thus obtained can be directly used for manual labor and support systems.

2、 血液相容性 材料的 各  2. Blood compatibility materials

以休外人工 其效果 將 0只大 分別 巴比 麻醉 腹腔制造局部 萬 細胞。 將步驟1 各的血液相容性 材料 細胞 休外 支持系統非 休內 血管相連 助作用 支持系統 大 5 。To effect 0 large babies were separately anesthetized in the abdominal cavity to produce local ten thousand cells. Connect the blood-compatible materials of step 1 to the extracellular support system and the non-endovascular support system to increase the support system 5.

2 血液相容性 材料的 各及效果  2 Blood compatibility materials and their effects

、 相容性 材料的 各  , Compatible materials

將 均分子量力20力的聚 由 均分子量力8力的聚 和有 的共聚 羊 有限公司 9 于1  The average molecular weight is 20 force, and the average molecular weight is 8 force.

中 高分于溶液。 將 高分子材料 、 由 和有 Medium to high score in solution. Polymer materials, You and You

的共聚 等 量的 磷灰石 于 醋酸 是 高分子材料 量的 0 的 y da o e 同加入上 高分于溶液中 混合 均勻 混合 。  The copolymerization of the same amount of apatite and acetic acid is a polymer material with an amount of 0.

將 由 形成的 放在 容器中 將上 各的混合 倒在其上, 非 到底部 在 2 C 各 的 材料 將 材料放入含量力0.5 的 形成 自 BMP 7 生理監水 中 吸附 形成蛋白 再 合一 0 溶液 于 得到血液相容性 材料。  Put the formed mixture in a container and pour the mixture on it, not the material at 2 C to the bottom. Put the material into the content of 0.5. Formed from the BMP 7 physiological monitoring water to form a protein and then unite 0 The solution is to obtain blood compatible materials.

2、 血液相容性 材料的  2. Blood compatibility materials

上 各的 材料可直接 于 材料或作力 于 、 再 生的可吸收性 。 下面 以牙再生的 其效果  The materials on the above can be directly on the materials or on the regenerative absorbability. Next, the effect of tooth regeneration

將 0只大 分別 巴比 麻醉 拔掉其中一根 , 在 中植入步驟 各的 材料 周圍肌肉 合。 木 6 Pull out one of the 0 big barbie anesthesias, and implant the materials around the muscles in the step. Wood 6

0只大 的血液相容性 材料不 , 0只大 的 中 又形成 新 。 0 large blood-compatible materials are not, and 0 large ones form new ones.

3 血液相容性 支架的 各及其效果  3 Blood compatibility and its effects

、 血液相容性 支架的 各  , Each of the blood compatibility stents

將 均分子量都 00 的 新 制品 醋酸 物資貿易有限公司 209 比 0 于 0 中 高分予混合溶液。  A new product with an average molecular weight of 00, Acetic Acid Materials Trading Co., Ltd. 209, was given a higher score than 0 to 0 in the mixed solution.

在上 各的溶液中再加入是高分子材料 和醋酸 0 的Na N 兩者的混合物 比 顆粒( 往小于 pm)作力 加入是高分于材料 和醋酸 Add polymer materials and acetic acid to the above solutions 0 Na N The mixture of the two is stronger than the particles (towards less than pm). It is higher in the material and acetic acid.

0. 的 基化硫酸 化 攪拌均勻 混合 。 0. The sulfation of the base is stirred and mixed evenly.

將上 混合 快速成形 各 0. 的管 材料。 在 材料 的管壁上打孔、 切割等 各 、 阿 內支架。  Mix the upper part for rapid prototyping 0. Tube material. Holes, cuts, etc. are made on the wall of the material.

將上 得的管 支架在 水中浸泡2 除去 得到 血液相容性 支架。  Soak the obtained tube holder in water 2 to remove the blood-compatible holder.

2、 血液相容性 支架的  2. Blood compatibility

上 各的管 材料可直接 于 、 食管系統、 管系統、 尿路系 、 道系統、 輸卵管系統及神 系統等的 或 。 下面 以食管系 統 的 其效果  The above tube materials can be directly connected to the esophagus system, tube system, urinary tract system, tract system, fallopian tube system and neurological system. The following is the effect of the esophagus system

將 0只大 分別 巴比 麻醉 露出 食管 剪斷2c 將上 材料 合。 木 8 0只大 的新食管 材料 夏完好 材料均不 。 Bare anesthesia to expose 0 esophagus, cut 2c and close the upper material. Wooden 80 new large esophagus materials, summer intact materials are not.

14 血液相容性 支架的 各及其效果  14 Blood compatibility and its effects

、 血液相容性 支架的 各  , Each of the blood compatibility stents

將 均分子量都 0 的聚碳酸 自 市三安化工有限公司 內 (P L 自 亦 錫市金峰化工有限公司) 9 重量比 0 1 加入到 有 二甲基正 中 再加入是高分于材料 碳 和 內 量的 的水 攪拌 。 溶液 由 0 銅 的 的支持 上 成一 支架。 將上 各的 支架放入 模具 倒入 的  Polycarbonate with an average molecular weight of 0 is from Sanan Chemical Co., Ltd. (PL from Yixi Jinfeng Chemical Co., Ltd.) 9 Weight ratio 0 1 is added to the middle of the dimethyl and then added is higher in the material carbon and internal content Water stirring. The solution is supported by 0 copper to form a bracket. Put the above brackets into the mold

自北京 康生物工程 中[ 溶液 于 0. M碳 Since Beijing Kang Biological Engineering [solution Yu 0. M carbon

E 水溶液 然 抽掉其中 的支持 得一血液相容性 器官 支架。  E aqueous solution then withdraws the support to obtain a blood compatible organ stent.

2、 血液相容性 支架的 各  2. Blood compatibility

上 各的血液相容性 支架 再將表皮細胞生 因子、 內皮細 胞 蛋白 凝血 混合 合在支架內表面 得到的材料可用于 、 、 或 等 器官 。 下面 以 器官 其效 將 0只大 分別 巴比 麻醉 她外 皮 取出其中脂肪 將 縫合 。 法分萬脂肪 中 的脂肪 細胞 大量 將 內皮細胞。 將0. mL消化萬 的 內 0.1 L 0. 的內皮細胞生 于 E F g a 5 U pB 溶液及1 0 蛋白 gma U 混合均勻 或 在 支架內表面 然 用放在5 L 00 U L凝血 PB 溶液中使其固化。 將 0只大 分別 巴比 麻醉 分別將 合了內皮細胞、 內皮細 胞生 因子和 蛋白的一介 的支架接到 小 的血管上 將外 皮 合。 木 將20 的 粉末 于 mL氯化鈉注射 中 0 然 腹部注入休內。 木 8 0只大 血管 形成 The materials obtained from the above blood-compatible scaffolds are mixed with epidermal growth factor and endothelial cell protein coagulation on the inner surface of the scaffolds, and can be used for organs such as,, and. The following is based on the effect of organs 0 big Barbie anesthetized her skin to remove the fat and suture it. A large number of fat cells in fat divided into endothelial cells. 0. 0.1 L in 0.1 mL digestion. The endothelial cells were born in EF ga 5 U pB solution and 10 protein gma U mixed evenly or placed in 5 L 00 UL coagulation PB solution to solidify on the inner surface of the stent. 0 large barbie anesthesias were used to connect endothelial cells, endothelial cell growth factor and protein-containing scaffolds to small blood vessels and the outer skin was closed. Mu injected 20 of the powder in mL of sodium chloride injection and then injected it into the abdomen. 80 large blood vessels formed

校入 材料 。 Proofreading materials.

5 相容性肝 前休的 各及其效果  5 Compatibility of liver anterior break and its effect

、 血液相容性肝 前休的 各  , Blood compatible liver

將 均分于 都 20力的乙烯 醋酸乙烯共聚 市三 有 比 限公司 丙烯 北京 百草科技木友 有限公司 9 比 加入 中 乙烯 醋酸乙烯共聚 丙烯 的混合 。 在 溶液中加入所用高分于材料 乙烯 醋酸乙烯共 聚 丙烯 0 NH 0作力 , 及高分于 材料 乙烯醋酸乙烯共聚 丙烯 0.00 的  Ethylene Vinyl Acetate Copolymer, which is divided equally in the capital of 20, is propelled by Sanyou Co., Ltd., Beijing Baicao Technology Muyou Co., Ltd. 9 to 9%, and is mixed with ethylene vinyl acetate copolymer propylene. Add the high content of the material used in the solution ethylene vinyl acetate copolymer propylene 0 NH 0 force, and the high content of the material ethylene vinyl acetate copolymer propylene 0.00

20 抑制 于0. L .1 磷酸 中 。 20 Restricted to 0. L.1 phosphoric acid.

成一 支架, 放入 相 的模具中。 倒入上 溶液 得一三 支架。  Form a bracket and put it into the corresponding mold. Pour the upper solution to get one or three racks.

將 0只新西 大 白兔分別 巴比 麻醉 她外皮, 取出其中脂肪 將 縫合 。 法分萬脂肪組 的 ?5 細胞 大量 將 內皮細胞。 將0. L消化萬 的內皮 細胞 溶解在 mL PB 溶液 然 在 支架內 。 將上 0只兔于分別 巴比 麻醉 分別將 合了其內皮細胞的一介 的支架接到 小 的血管上, 將外皮縫合。 木 將20 單位的 粉末 于 L氯化鈉注射 然 腹部注入休內。 木 12 30 10只兔子血管 形成 材料均未 。 2、 血液相容性肝 前休的 物安 0 New Zealand white rabbits were Barbie anesthetized her skin, and the fat was taken out and sutured. A large number of ~ 5 cells in the fat group of fat will endothelial cells. 0. L-digested endothelial cells were dissolved in mL PB solution and then placed in the stent. The upper 0 rabbits were respectively anesthetized with Babi anesthetized, and the stents incorporating their endothelial cells were connected to small blood vessels, and the skin was sutured. Mu injects 20 units of powder into L-sodium chloride injection and then into the abdomen. None of the 10 12 rabbits had vascular forming materials. 2. The blood compatibility of the liver

將 0只大 分別 巴比 麻醉 她外 皮 取出其中脂肪 將 縫合 。 解法分萬脂肪組 中 的脂肪 細胞 大量 將 內皮細胞。 將0. 萬 的 內皮細胞 0. L 0. 內皮細胞生 于 E F g a U PB 溶液及 L 0 蛋白 g a U 混合均勻, 或 在 支架內表面 然 用放在5 L 00 U L凝血 PB 溶液中使其固化。 將 0只大 分別 巴比 麻醉 將 合有內皮細胞、 內皮細胞生 予和 蛋白一介 的支架接到 小 的血管上 將外皮 合。 木 將20 的 粉末 于 mL氯化鈉注射 中 然 腹部注入休內。 木 2 0只大 的血管 形成 細胞 校 入 材料均不 。 Barbie anesthetize her skin, remove the fat and sew it. A large number of fat cells in the fat group will endothelial cells. 0. Million endothelial cells L 0. Endothelial cells produced in E F g a U PB solution and L 0 protein g a U are mixed evenly, or they can be solidified in 5 L 00 U L coagulation PB solution on the inner surface of the stent. Anesthetize 0 large barbie anesthesia. Connect the endothelial cells, endothelial cell production and protein-mediated scaffolds to the small blood vessels to join the outer skin. Mu inject 20% of the powder in mL of sodium chloride injection and then abdomen into the stomach. There are no materials for the 20 large blood vessel forming cells.

6 血液相容性 阿支架材料的 各及其效果 、 血液相容性 支架材料的 各  6 Hemocompatibility A stent material and its effect, blood compatibility Stent material

將 均分于 都 20力的高分子材料 乙烯 表面 木 有限公司 29 5 1的 比加入到 氯仿中  Add a polymer material that is evenly divided into the 20 strengths of Ethylene Surface Wood Co., Ltd. 29 5 1 to chloroform

乙烯 素的混合溶液。 在溶液中加入所用高分于材料 乙 烯 量的 0 的NHH 作力 是高分于材料 乙烯並 量的4 的多 及是高分子材料 1 的 氧 抑制 混合均勻 高分子混合 。  A mixed solution of vinyl. Adding NHH with a high content of 0 in the amount of ethylene used in the solution is more than 4 in the amount of ethylene in the material and the oxygen content of the polymer material 1 is evenly mixed. Polymer mixing.

將上述高分于混合 木 各 固 致密的元 仟 阿 2c X2cm , 阿 放入一圓柱狀模具 加入上 各的溶液 2 C下 、 水中浸泡 得一元 阿支架材 料。 Divide the above high scores into the dense and dense Yuan Yuan 2c X2cm of the mixed wood, put it into a cylindrical mold, add the solution of each above 2 C, and soak in water to obtain the Yuan Yuan stent material.

2、 血液相容性 仟 阿支架材料的  2. Hemocompatibility of thousands of scaffold materials

將 0只大 D 分別 巴比 麻醉 她外 皮, 取出其中脂肪 將 縫合 。 解法分萬脂肪 中 的脂肪 細胞 大量 將 細胞。 將0 L消化萬 的成 0. L 0 的表皮細胞生 因子 E F g a U PB 溶液混合均勻, 或 在支架內表面。 將 0只大 巴比 麻醉 在其背部 下一 將 合有成 細胞、 表皮 細胞生 于的元 阿支架材料 合在 上。 木 將20 的 粉末 于 L氯化 注射 中 然 腹部注入休內。 木 6 0只大 的表皮 材料均不 。Barbie anesthetizes her skin with 0 big D, removes the fat and sews it. A large number of fat cells in fat cells will be divided into cells. Digest 0 L into 10,000. The solution of the epidermal growth factor EF ga U PB of L 0 is mixed evenly, or on the inner surface of the stent. 0 big Barbie anesthetized the scaffold material with metablasts and epidermal cells on the back of his body. Mu injected 20 powders into the abdomen during L chloride injection. None of the 60 large skin materials of wood.

7 血液相容性 的 各及其 效果  7 Each of blood compatibility and its effect

1、 相容性 的 各  1. Compatibility

將 均分予 都 20 的聚 丁酸 (PHB) 由 、 有 及聚 的共聚 南 制品有限責任公司 29 2的 比 于1 高分于材料的混合 。 再 在 溶液中加入是高分于材料 PHB和由 、 有 住及聚  The polybutyric acid (PHB), which is evenly distributed to the metropolis 20, is composed of copolymers, copolymers, and poly products. South Products Co., Ltd. 29 The ratio of 2 to 1 is higher than 1 for the mixing of materials. Adding in the solution is a high score in the material PHB and by, living and polymerization

的共聚 的抗凝血 及是 高分于材料 0 的 NH 0,作力 加入是PHB 量的0. 的吉尼 ge p 水溶液形式加入 充分攪拌均勻 血液相容性高分子混合溶液。 將上述 各的血液相容性高分子混合溶液 竺法制各元 將 各的元 材料放入 水 浸泡 再 。  The copolymerized anticoagulant is NH 0 which is higher than the material 0, and the force added is 0% of PHB. The Gini ge p aqueous solution is added in the form of a well-mixed blood-compatible polymer mixed solution. Each of the above-mentioned blood-compatible polymer mixed solutions was prepared by Zhufa method, and each element material was immersed in water.

2、 血液相容性 的 各  2. Each of the blood compatibility

將 0只大 分別 20 麻醉 她外皮 取出其中脂肪 將 縫合 。 法分萬脂肪 中的脂 肪 細胞 大量 將 細胞。 將0. L消化萬 的成 細胞 0. L 0.1 的表皮細胞生 于 E F gma U PB 溶液混合均勻, 或 在支架內表面。 將上 大 分別 20 麻醉 在其背部 下一 將 合有其成 、 表皮細胞生 于的元 阿支架材料縫合在 上。 木 將20 的 粉末 于 mL氯化 注射 然 腹部注入休內。 木 2 Anesthetize 0 animals, 20, anesthetize her skin, remove the fat, and sew it. Fat cells in fat are divided into a large number of cells. 0. L digests 10,000 adult cells. The epidermal cells of L 0.1 are produced in E F gma U PB solution and mixed evenly, or on the inner surface of the stent. Anesthetize the upper and the lower 20 respectively on its back and suture the Yuan-A scaffold material with epithelial cells and epidermal cells. Mu inject 20% of the powder in mL of chlorinated injection and then inject it into the abdomen. Wood 2

10只大 的表皮 材料 。 10 large skin materials.

8 血液相容性 材料的 各及其 效果 、 血液相容性 材料的 各  8 Blood compatibility materials and their effects, blood compatibility materials

將 9 PHB )(按照文 osh e N a o noue . c u a a s o O a e a C ys a s n a so o phousCopo y e Po y(3 hyd oxyb y a e co 3 hyd oxyva e a e). ac o o ecu es. 200 26) 953 8960中 的 方法制各) 于 中 9 L PHB 溶液 再加入 2 水溶液 混合均勻 。 一份加入是 量的 0 的右旋 均分子量 4000 另一份不 右旋 。 在一根玻璃 上 先 右旋 的高分子溶液 再 不含右旋 的高分 于溶液 外 右旋 的高分子溶液, 形成一 材料 然 將 材料 0.1 水溶液中 血液相容性 材料的 物安 Will 9 PHB) (according to the text osh e N ao noue. Cuaaso O aea C ys asna so o phous Copo ye Po y (3 hyd oxyb yae co 3 hyd oxyva eae). ac oo ecu es. 200 26) 953 8960 made in the method) in the 9 L PHB solution and then add 2 aqueous solutions to mix. One portion is added with an amount of 0 for the right-handed molecular weight of 4000 and the other portion is not right-handed. A polymer solution that is right-handed on a piece of glass and then does not contain a right-handed polymer solution with a high score of right-handedness outside the solution forms a material that holds the material 0.1

此 材料可用于 休各 鎳的 也可在其上下 表面 合內皮細胞、 乎 細胞及成 細胞 用做 、 、 血 管、 等的替代物。 下面 以食管 的 物安 效果  This material can be used as a substitute for nickel, and can also be used on the upper and lower surfaces of endothelial cells, vascular cells, and adult cells. Below is the physiotherapy effect of esophagus

將 0只大 分別 20 麻醉 她外皮 取出其中脂肪 將 縫合, 。 解法分萬脂肪組 中的 千細胞 大量 將 內皮細胞、 乎 細胞及成仟 細胞。 將0. L消化萬 的內皮細胞、 平滑 細胞及成仟 細胞 物分別 L pB 溶液混合均勻 或 在 材料內表面。 將上述大 分別 20 麻醉 將 食管切斷6 將所制各的管 材料縫合在 上。 木 將20刀車位的 粉末 于 L氯化鈉注射 然 注入休內。 木 24 大 的食管 材料 。 此 用  Anesthetize her 0 skins and 20 skins, remove the fat and sew it. A large number of thousands of cells in the fat group will be divided into endothelial cells, almost cells and thousands of cells. 0. The endothelial cells, smooth cells and thousands of cells of L-digestion are mixed in the L pB solution or on the inner surface of the material. Anesthetize each of the above 20, cut the esophagus 6 and sew each tube material to the top. Wood Inject powder of 20 knives in L sodium chloride and inject it into the container. Wooden 24 large esophagus material. This use

本投明的方法將具有較高 械性能的 高分子材料和抗凝血材料 神不同的溶 溶解 可將抗凝血材料均勻 固定在高分于材料中 常規的方法制各出外用或休 植入的 器官 材料 克服了 木中只在 表面 吸附、 或接枝 抗凝血 所帶來的效果不明 思或 阿很短暫的弊端。 本投明的血液相容性材料不 具有較好的抗凝血性 能 而且延後了抗凝血的奉命 同 滿足外用或休內植入的組 器官 材料所需求的具有良好的抗凝血性、 生物相容性、 較高的 強度和韌性等 等多方面性能要求。 物安 方法和 表明 所用材料在短期內 如一介 內 可 內 在 3 m 2 3c 的兔 和靜脈。 內不合引起炎 症、 仟 包裹、 血栓、 脈瘤、 鈣化等不良反 是 很有前途和市 的多功能 生物材料。 The obvious method of dissolving and dissolving polymer materials with high mechanical properties and anticoagulant materials can uniformly fix the anticoagulant materials in the high score in the material. Conventional methods are used for external use or implantation The organ material overcomes the shortcomings that the effect of the wood is only absorbed on the surface, or the anticoagulant effect of grafting is unclear or very short. The proven blood-compatible materials do not have good anticoagulant properties and delay the anticoagulant orders. They also have good anticoagulant and biological properties to meet the needs of tissue materials for external or internal implant Compatibility, high strength and toughness, and many other performance requirements. The material safety method and the materials used showed that within a short period of time, such as within 3 m 2 3c of rabbits and veins. Internal discomforts that cause inflammation, thousands of packages, thrombosis, hemangioma, calcification and other undesirable effects are promising and multifunctional biomaterials.

Claims

要求 1. 各血液相容性材料的方法 是將分子量力 0 的 高分子材料 于有 中 百分含量力0. gn 的高分于 Requirements 1. The method of each blood-compatible material is to convert the polymer material with a molecular weight of 0 to a percentage of 0. gn's high score is 將抗凝血材料用 溶解, 形成乳狀、 漿狀或 休 然 按 照下 1 或2 或3 方法得到血液相容性材料  Dissolve the anticoagulant material to form a milky, syrupy, or still. Follow steps 1 or 2 or 3 to obtain a blood-compatible material 將 高分子溶液和 抗凝血材料乳狀、 漿狀或 休 混 合 的休外 材料或休內植入的組 器官 材料 即 血液相容 性材料 Extracorporeal materials mixed with polymer solutions and anticoagulant materials in milky, pasty, or interstitial groups 2 將 高分于溶液、 抗凝血材料乳狀、 漿狀或 休 物和 混合 休外 材料或休內植入的組 器官 材料 除去 得到血液相容性材料 是 高分于材料 量的9 或20 以下  2 Removal of high-resolution materials, milky, syrupy or anti-coagulant materials and mixed extra-orthopedic materials or implanted organ materials to obtain blood compatible materials is 9 or 20 the following 3 將 高分于溶液 抗凝血材料乳狀、 漿狀或 休 物和填充 混合 休外 材料或休內植入的組 器官 材料 即 血 液相容性材料 所述填充 是 高分子材料 量的的 或9 以 下 3 Highly categorize the anti-coagulant solution milky, syrupy or rest materials and fill the mixed rest materials or the tissue materials implanted inside the rest, that is, the blood compatible materials. The filling is the amount of polymer materials or 9 following 1 或2 或3 中所述的抗凝血材料是 高分子材料 量 的0. 001 0 % 001 0% The anticoagulant material described in 1 or 2 or 3 is a polymer material 2 要求1 的方法 其特 在于 高分于材料力 、 有 的共聚 、 內 的共聚 、 乙烯碳酸 、 碳酸 、 丙烯 、 芳香 、 4 丁酸和 _ 共聚 、 乳酸、 內 、 乳酸 共聚 、 3 丁酸 、 、 、 、 氧乙烯、 醋酸乙烯共聚 、 、 、 聚氯乙烯、 聚丙烯 、 、 丙烯 、 碳酸 、 、 、 、 或它們的衍生物 醋酸 、 、 聚氯乙烯、 二甲 的共 聚 、 有 及聚 的共聚 、  2 The method of requirement 1 is characterized by a high score in material strength, some copolymerization, internal copolymerization, ethylene carbonate, carbonic acid, propylene, aromatic, 4 butyric acid and _ copolymerization, lactic acid, internal, lactic acid copolymerization, 3 butyric acid, ,,, Ethylene oxide, vinyl acetate copolymerization,,, polyvinyl chloride, polypropylene, propylene, carbonic acid,,, or their derivatives acetic acid,, polyvinyl chloride, dimethyl copolymerization, copolymerization, and copolymerization, 乙烯 中的一 或 的混合物 所述抗凝血生物材料力 、 凝血 、 、 腎上腺素、 、 、 、 阿 、 、 它 、 、 基化硫酸 化 、 水 、 抑制 或 氧 抑制 蔗糖、 右旋 、 Na NHH 、 H) 、 N NL 或Na (NH) 0的混合物 的填充物力 磷灰石、 磷酸鈣。One or a mixture of ethylene, the anticoagulant biomaterial, coagulation, epinephrine,,,,, , It, basified sulfation, water, inhibition or oxygen inhibition of sucrose, dextrose, Na NHH, H), N NL or Na (NH) 0 mixture of filling apatite, calcium phosphate. R 要求 的方法 其特 在于 有 4 二氧 、 怪、 、 二氧 、 氫 、 氯仿、 二甲 或二甲 並 或 以上混合 。  The method required by R is characterized by the presence of 4 dioxins, blazes, dioxins, hydrogen, chloroform, dimethyl or dimethyl and a combination of the above. 4. 要求 的方法 其特 在于 力水 生 理監水、 磷酸 、 溶液或 水。  4. The required method is characterized by the physiologic monitoring water, phosphoric acid, solution or water. 1 R. 要求 的方法 其特 在于 混合物用 、 、 、 竺法、 快速成形或 法制各成材料均 或 的薄膜 、 、 中空 、 、 狀或 的血液相溶性 的休外 材料或休內植入的 器官 材料。 1 R. The required method is characterized in that the mixture is made of a thin film, a hollow, a, or a blood-compatible restorative material or an organ material implanted within the rest of the material by using the method, the method, the rapid method, or the method. 6 要求 的方法 其特 在于 是用水或 水溶液浸泡除去。  6 The required method is characterized in that it is removed by immersion in water or an aqueous solution. 7. 要求 的方法 其特 在于 抗凝血材料 如 下方法她 將抗凝血材料用 溶解 在溶解 的抗凝血材料 中加入是抗凝血材料的 量的0 0 冗的交 反 反 用水或 水溶液浸泡 除去 的 N g.n 即 碳 、 碳 2 N 磺酸系 統、 、 多 或吉尼 。  7. The required method is characterized in that the anticoagulant material is as follows: she will dissolve the anticoagulant material in the dissolved anticoagulant material and add the amount of anticoagulant material. N gn means carbon, carbon 2 N sulfonic acid system,, poly or gin. 8. 要求5 的方法 其特 在于 狀或阿 而液 相容性材料 其內外表面 合內皮細胞、 乎 細胞、 細 胞、 、 細胞、 胰島 或心肌細胞或將所述細胞 、 仟  8. The method of claim 5 is characterized by a liquid or liquid compatible material whose inner and outer surfaces are combined with endothelial cells, cells, cells, cells, islets or cardiomyocytes or the cells, thousands 凝血 混合 注射器注入管道系統 形成的 中 各 器官 材料。  Coagulation and mixing syringes are injected into the piping system to form materials in various organs. 9. 要求8所述的 各方法,其特 在于 在 或注射 細 胞的同 在 材料表面或內部 合 、 、 于或血清。  9. The method according to claim 8, which is characterized in that the cell is injected with or on the surface of or inside the material, or the serum is combined. 1 要求 9中任 所 的 各方法制各的血液相容性生物材料。  1 Requires any of the methods in any of the nine methods to make blood-compatible biomaterials.
PCT/CN2006/003304 2005-12-09 2006-12-06 A material with blood compatibility and preparation method thereof Ceased WO2007065359A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 200510126364 CN1799649A (en) 2005-12-09 2005-12-09 Blood compatible biological material and preparation method thereof
CN200510126364.5 2005-12-09

Publications (1)

Publication Number Publication Date
WO2007065359A1 true WO2007065359A1 (en) 2007-06-14

Family

ID=36810007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2006/003304 Ceased WO2007065359A1 (en) 2005-12-09 2006-12-06 A material with blood compatibility and preparation method thereof

Country Status (2)

Country Link
CN (1) CN1799649A (en)
WO (1) WO2007065359A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109937055A (en) * 2016-11-07 2019-06-25 郡是株式会社 Biological tissue's reinforcing material and artificial dura mater
CN110129259A (en) * 2018-02-02 2019-08-16 安徽中医药大学 Application of liquid crystal phase structure engineering film
CN114813270A (en) * 2022-04-08 2022-07-29 南雄阳普医疗科技有限公司 Blood coagulant and preparation method and application thereof
CN116271263A (en) * 2023-02-07 2023-06-23 广州医科大学 A kind of composite reinforced degradable material and its preparation method and application
WO2024255267A1 (en) * 2023-06-14 2024-12-19 国际可盛有限公司 Xenotransplantation colloid set and use method thereof
CN119431862A (en) * 2024-09-12 2025-02-14 北京化工大学 Modified PET material with good blood compatibility and antibacterial ability, preparation method and application thereof
CN119857166A (en) * 2025-01-15 2025-04-22 青岛中惠圣熙生物工程有限公司 PDO barb suture with antibacterial coating and preparation method thereof

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008041183A2 (en) 2006-10-05 2008-04-10 Technion Research & Development Foundation Ltd. Microtubes and methods of producing same
US9096845B2 (en) 2007-08-29 2015-08-04 Technion Research & Development Foundation Limited Encapsulation of bacteria and viruses in electrospun fibers
WO2009104175A2 (en) 2008-02-21 2009-08-27 Technion Research & Development Foundation Ltd. Use of electrospun microtubes for drug delivery
CN101844043A (en) * 2010-05-25 2010-09-29 东华大学 Co-mixing film of ethylene-acetic acid ethylene copolymer and polysulfone and method for preparing same
CN101845433B (en) * 2010-05-25 2012-06-27 中国科学院过程工程研究所 Preparation method of polyurethane nanofiber immobilized enzyme
CN102068323B (en) * 2011-01-21 2014-03-26 南京师范大学 Cardiac or vascular patch with anticoagulant effect
CN102501344B (en) * 2011-09-29 2014-07-16 华东交通大学 Method for constructing hemocompatible material surface with bionic periodic structure
CN103087219B (en) * 2011-12-30 2014-11-26 北京大学 Dentritic heparin nano-material modified biological type artificial blood vessel
CN103087218B (en) * 2011-12-30 2016-01-20 北京大学 The biotype artificial blood vessel that straight chain shape is heparin modified
CN102618954B (en) * 2012-03-19 2014-06-25 嘉兴强特生物科技有限公司 Human serum albumin nano biomaterial and preparation method thereof
CN103301506B (en) * 2013-06-21 2015-03-04 苏州大学 Anticoagulation fibroin membrane and preparation method thereof
CN104213211B (en) * 2014-09-18 2016-06-08 东华大学 A kind of method preparing doughnut artificial blood vessel for raw material with polycaprolactone
WO2016169041A1 (en) * 2015-04-24 2016-10-27 Gunze Limited Biological tissue-reinforcing material
CN104894748A (en) * 2015-05-20 2015-09-09 苏州市贝克生物科技有限公司 Carbon fiber/polyester hemodialysis membrane and preparation method thereof
CN104894747A (en) * 2015-05-20 2015-09-09 苏州市贝克生物科技有限公司 Polysulfone fiber hemodialysis membrane and preparation method thereof
CN104874302A (en) * 2015-05-20 2015-09-02 苏州市贝克生物科技有限公司 Cellulose acetate/povidone hematodialysis membrane and preparation method thereof
CN105126787B (en) * 2015-08-03 2017-06-06 佛山市博新生物科技有限公司 A kind of method for improving adsorbent anticoagulant property
CN105463848A (en) * 2015-12-17 2016-04-06 华南理工大学 Preparation method of oriented shish-kebab fiber
CN111803711B (en) * 2016-12-28 2022-03-29 广州迈普再生医学科技股份有限公司 Composite tissue repair patch prepared by freeze drying process and preparation method thereof
CN107693846B (en) * 2017-09-29 2019-09-27 清华大学 A kind of biomimetic vascularized soft tissue with multilayer vascular structure and its preparation method
CN108273117A (en) * 2018-02-28 2018-07-13 苏州凌科特新材料有限公司 A kind of preparation method of Medical absorbable hemostatic material
CN108939934B (en) * 2018-07-31 2021-04-09 哈工大(威海)创新创业园有限责任公司 Biocompatible magnetic porous membrane material and preparation method thereof
CN109893684A (en) * 2019-02-11 2019-06-18 赵延延 A kind of preparation method of the compound anticoagulant biomaterial of carboxymethyl chitosan
CN111472093A (en) * 2020-04-08 2020-07-31 武汉理工大学 Nano-hydroxyapatite/polylactic acid composite fiber membrane and preparation method thereof
CN115120787B (en) * 2022-06-30 2023-06-23 上海翊科聚合物科技有限公司 Preparation method and application of a hemodialysis composite membrane
CN116211534A (en) * 2022-12-30 2023-06-06 苏州瑞济诺医疗科技有限责任公司 Hernia repair patch and method of making the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1128497A (en) * 1994-05-17 1996-08-07 株式会社大塚制药工场 Method for preventing blood coagulation in extracorporeal circulation of blood and antithrombotic drug releasing device applied thereto
US6589548B1 (en) * 1998-05-16 2003-07-08 Mogam Biotechnology Research Institute Controlled drug delivery system using the conjugation of drug to biodegradable polyester
JP2004002982A (en) * 2002-03-26 2004-01-08 Jfe Steel Kk Surface treated steel sheet
CN1569253A (en) * 2004-04-23 2005-01-26 清华大学 Preparation method of hematopoietic tissue repairing material
US6861064B1 (en) * 1997-10-23 2005-03-01 Jagotec Ag Encapsulation method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1128497A (en) * 1994-05-17 1996-08-07 株式会社大塚制药工场 Method for preventing blood coagulation in extracorporeal circulation of blood and antithrombotic drug releasing device applied thereto
US6861064B1 (en) * 1997-10-23 2005-03-01 Jagotec Ag Encapsulation method
US6589548B1 (en) * 1998-05-16 2003-07-08 Mogam Biotechnology Research Institute Controlled drug delivery system using the conjugation of drug to biodegradable polyester
JP2004002982A (en) * 2002-03-26 2004-01-08 Jfe Steel Kk Surface treated steel sheet
CN1569253A (en) * 2004-04-23 2005-01-26 清华大学 Preparation method of hematopoietic tissue repairing material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LV QIANG ET AL.: "Preparation and blood compatability of polyurethane films blending and grafting with heparin in the same solvent system", CHINESE JOURNAL OF MATERIALS RESEARCH, vol. 18, no. 3, June 2004 (2004-06-01), pages 251 - 256 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109937055A (en) * 2016-11-07 2019-06-25 郡是株式会社 Biological tissue's reinforcing material and artificial dura mater
CN110129259A (en) * 2018-02-02 2019-08-16 安徽中医药大学 Application of liquid crystal phase structure engineering film
CN114813270A (en) * 2022-04-08 2022-07-29 南雄阳普医疗科技有限公司 Blood coagulant and preparation method and application thereof
CN114813270B (en) * 2022-04-08 2024-04-19 南雄阳普医疗科技有限公司 Blood coagulant, preparation method and application thereof
CN116271263A (en) * 2023-02-07 2023-06-23 广州医科大学 A kind of composite reinforced degradable material and its preparation method and application
WO2024255267A1 (en) * 2023-06-14 2024-12-19 国际可盛有限公司 Xenotransplantation colloid set and use method thereof
CN119431862A (en) * 2024-09-12 2025-02-14 北京化工大学 Modified PET material with good blood compatibility and antibacterial ability, preparation method and application thereof
CN119857166A (en) * 2025-01-15 2025-04-22 青岛中惠圣熙生物工程有限公司 PDO barb suture with antibacterial coating and preparation method thereof

Also Published As

Publication number Publication date
CN1799649A (en) 2006-07-12

Similar Documents

Publication Publication Date Title
WO2007065359A1 (en) A material with blood compatibility and preparation method thereof
Wu et al. Tissue-engineered vascular grafts: balance of the four major requirements
Zhu et al. Covalent grafting of PEG and heparin improves biological performance of electrospun vascular grafts for carotid artery replacement
Martin et al. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial
US9737632B2 (en) Fiber scaffolds for use creating implantable structures
Saito et al. Challenges and possibilities of cell-based tissue-engineered vascular grafts
EP1443982A2 (en) Porous polymeric prostheses and methods for making same
Shen et al. Progress on materials and scaffold fabrications applied to esophageal tissue engineering
CN1694955A (en) Programmable scaffold and methods for making and using the same
Guang et al. Design and preparation of polyurethane-collagen/heparin-conjugated polycaprolactone double-layer bionic small-diameter vascular graft and its preliminary animal tests
Fang et al. Fabrication of heparinized small diameter TPU/PCL bi-layered artificial blood vessels and in vivo assessment in a rabbit carotid artery replacement model
Yin et al. Performance of PEGylated chitosan and poly (L-lactic acid-co-ε-caprolactone) bilayer vascular grafts in a canine femoral artery model
Sun et al. Direct thrombin inhibitor-bivalirudin improved the hemocompatibility of electrospun polycaprolactone vascular grafts
Li et al. The loading of C-type natriuretic peptides improved hemocompatibility and vascular regeneration of electrospun poly (ε-caprolactone) grafts
RU2504406C1 (en) Method for making bioresorbed small-diameter hybrid vascular graft
Mohamed et al. Renal tissue engineering for regenerative medicine using polymers and hydrogels
Conconi et al. Evaluation of vascular grafts based on polyvinyl alcohol cryogels
Xiao et al. Fabrication of small-diameter in situ tissue engineered vascular grafts with core/shell fibrous structure and a one-year evaluation via rat abdominal vessel replacement model
JP2003126125A (en) Artificial blood vessel and method of preparing it
Perego et al. Functionalization of poly-L-lactic-co-ε-caprolactone: Effects of surface modification on endothelial cell proliferation and hemocompatibility
Liu et al. Enhanced hemocompatibility and rapid magnetic anastomosis of electrospun small-diameter artificial vascular grafts
He et al. Developing an anticoagulant microfibrous vascular graft with enhanced kink resistance and self-sealing capabilities
Zhang et al. Nanofibers with homogeneous heparin distribution and protracted release profile for vascular tissue engineering
Uretzky et al. Long-term evaluation of a new selectively biodegradable vascular graft coated with polyethylene oxide-polylactic acid for right ventricular conduit: an experimental study
CN119158076A (en) A bacterial nanocellulose composite tube and its preparation method and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06828256

Country of ref document: EP

Kind code of ref document: A1